Share this:
Vaxxas announced the publication in the journal PLoS Medicine of groundbreaking clinical research indicating the broad immunological and commercial potential of Vaxxas’ novel high-density microarray patch (HD-MAP). Using influenza vaccine, the clinical study of Vaxxas’ HD-MAP demonstrated significantly enhanced immune response compared to vaccination by needle/syringe. Vaccine on HD-MAP is shown to be stable for 12 months at temperatures as high as 40oC. This is the largest microarray patch clinical vaccine study ever performed.
More Stories
Will County, Illinois 1864 Map – May 20, 2023 at 04:14AM
This kid on Google Map trying to get by – April 27, 2023 at 05:05PM
World of Hyatt: Complete list of all-inclusive properties in Europe (with map) – April 27, 2023 at 04:57PM